A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
about
Trial watch: Immune checkpoint blockers for cancer therapy.A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumors?Perspective on cytoreduction and metastasis-directed therapy in node positive and metastatic urothelial carcinoma of the bladder.Pembrolizumab for the treatment of bladder cancer.Pembrolizumab combined with stereotactic body radiotherapy in a patient with human immunodeficiency virus and advanced non-small cell lung cancer: a case report.Effects of radiation on the metastatic process.Tumor Regression and Cure Depends on Sustained Th1 Responses
P2860
Q47393365-3A2B3C37-A285-4E98-B733-3297537DF130Q48319161-EC088CE4-B970-4D1A-B81B-D4CE5335577DQ49031712-E12A7FD2-DAC5-489A-B364-4D648BCE44EAQ49036770-EA208156-43BE-443D-A98A-23A6C70BB234Q55079562-E20E6915-062E-4ABA-B442-95ED97F8EF3FQ55417312-2DA560E0-F1D1-421A-8418-703D6B2147E8Q56876356-622EC888-35B1-4674-9C96-C242106B662A
P2860
A phase I/II trial of fixed-dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
A phase I/II trial of fixed-do ...... nical and immunologic response
@ast
A phase I/II trial of fixed-do ...... nical and immunologic response
@en
type
label
A phase I/II trial of fixed-do ...... nical and immunologic response
@ast
A phase I/II trial of fixed-do ...... nical and immunologic response
@en
prefLabel
A phase I/II trial of fixed-do ...... nical and immunologic response
@ast
A phase I/II trial of fixed-do ...... nical and immunologic response
@en
P2093
P2860
P1476
A phase I/II trial of fixed-do ...... nical and immunologic response
@en
P2093
Annabel Meireson
Daan De Maeseneer
Dries Reynders
Els Goetghebeur
Karel Decaestecker
Katrien De Wolf
Lieve Brochez
Mireille Van Gele
Pieter De Visschere
P2860
P2888
P356
10.1186/S12967-017-1251-3
P50
P577
2017-06-29T00:00:00Z
P6179
1090298592